208 related articles for article (PubMed ID: 16482605)
21. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
Galizia G; Lieto E; Ferraraccio F; De Vita F; Castellano P; Orditura M; Imperatore V; La Mura A; La Manna G; Pinto M; Catalano G; Pignatelli C; Ciardiello F
Ann Surg Oncol; 2006 Jun; 13(6):823-35. PubMed ID: 16614884
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
[TBL] [Abstract][Full Text] [Related]
24. Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes.
Li JQ; Kubo A; Wu F; Usuki H; Fujita J; Bandoh S; Masaki T; Saoo K; Takeuchi H; Kobayashi S; Imaida K; Maeta H; Ishida T; Kuriyama S
Int J Oncol; 2003 May; 22(5):1101-10. PubMed ID: 12684677
[TBL] [Abstract][Full Text] [Related]
25. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
Ebert MP; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz HU; Roessner A; Korc M; Malfertheiner P
Cancer Res; 2000 Apr; 60(7):1995-2001. PubMed ID: 10766190
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
[TBL] [Abstract][Full Text] [Related]
27. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
28. Relationship between postoperative recurrence and expression of cyclin E, p27, and Ki-67 in non-small cell lung cancer without lymph node metastases.
Takahashi S; Kamata Y; Tamo W; Koyanagi M; Hatanaka R; Yamada Y; Tsushima T; Takaya S; Fukuda I
Int J Clin Oncol; 2002 Dec; 7(6):349-55. PubMed ID: 12494250
[TBL] [Abstract][Full Text] [Related]
29. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma.
Masuda TA; Inoue H; Nishida K; Sonoda H; Yoshikawa Y; Kakeji Y; Utsunomiya T; Mori M
Clin Cancer Res; 2003 Nov; 9(15):5693-8. PubMed ID: 14654553
[TBL] [Abstract][Full Text] [Related]
30. The loss of p27 protein has an independent prognostic significance in gastric cancer.
Kwon OJ; Kang HS; Suh JS; Chang MS; Jang JJ; Chung JK
Anticancer Res; 1999; 19(5B):4215-20. PubMed ID: 10628377
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of metallothionein in human gastrointestinal cancer.
Janssen AM; van Duijn W; Kubben FJ; Griffioen G; Lamers CB; van Krieken JH; van de Velde CJ; Verspaget HW
Clin Cancer Res; 2002 Jun; 8(6):1889-96. PubMed ID: 12060633
[TBL] [Abstract][Full Text] [Related]
32. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of metallothionein predicts chemoresistance in breast cancer.
Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclin genes in human gastric cancer and in first degree relatives.
Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
[TBL] [Abstract][Full Text] [Related]
35. Identification of bladder cancer patients at risk for recurrence or progression: an immunohistochemical study based on the expression of metallothionein.
Hinkel A; Schmidtchen S; Palisaar RJ; Noldus J; Pannek J
J Toxicol Environ Health A; 2008; 71(13-14):954-9. PubMed ID: 18569601
[TBL] [Abstract][Full Text] [Related]
36. Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classification.
Takeno S; Noguchi T; Takahashi Y; Fumoto S; Shibata T; Kawahara K
Ann Surg Oncol; 2007 Apr; 14(4):1431-8. PubMed ID: 17260107
[TBL] [Abstract][Full Text] [Related]
37. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
38. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract][Full Text] [Related]
39. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR
J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123
[TBL] [Abstract][Full Text] [Related]
40. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
